Vancomycin Dose Optimization in Obesity

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions
Pharmacokinetics and Pharmacodynamics
Interventions
DRUG

Vancomycin (IV)

Vancomycin weight-based or kidney function-based dosing

Trial Locations (1)

48108

RECRUITING

Michigan Clinical Research Unit, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER